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EXPLORING A NOVEL NF-ĸB- INHIBITING NANOPARTICLE FOR 
PERIODONTITIS THERAPY 
Kameswara Satya Srikanth Upadhyayula 
April  2017  
Periodontitis is an infection-driven inflammatory disease characterized by gingival 
inflammation and bone loss. The NF-ĸB signaling pathway is pivotal in 
osteoclastogenesis and infection-induced pro-inflammatory responses. The use of 
nanoparticles as a vehicle to deliver drug increases stability, loading capacity, and 
facilitates transmembrane transportation. The hypothesis was that a novel 
nanoparticle carrying therapeutic NBD inhibitory peptides (NBD-nanoparticles) will 
inhibit measures of periodontal disease. In this project, we tested the nanoparticles 
for their ability to directly inhibit osteoclastogenesis and inflammation as an original 
strategy for periodontitis therapy. We also tested the capability of the nanoparticles 
to inhibit gingival inflammation and alveolar bone loss in an animal model. 
Methods: In vitro- In order to test the impact of NBD-nanoparticles on 
osteoclastogenesis, RAW 264.7 cells were stimulated using RANKL and treated 
with NBD-nanoparticles. Controls included treatment with empty nanoparticles and 
no treatment. Seven days later, the cultures were fixed and stained with 
 vi 
TRAP, an osteoclast marker, and the number of multinucleated TRAP positive 
cells were counted. 
In order to test the impact of NBD-nanoparticles on pro-inflammatory responses, 
RAW or THP1 cells were stimulated with the periodontal pathogen P. gingivalis, 
treated with NBD-nanoparticles or empty nanoparticle and tested for expression of 
cytokines critical in periodontitis, such as IL-1β, IL-6, TNFα by ELISA. Differences 
were evaluated by ANOVA. 
In vivo - NBD-nanoparticles were tested in a murine ligature-induced periodontitis 
model where mice received a ligation around the second molar, P. gingivalis 
infection and microinjections of NBD-nanoparticles, empty nanoparticles, or PBS 
in the gingiva. Gingival tissue was tested for mRNA expression of pro-inflammatory 
cytokines by real-time PCR. Alveolar bone loss was determined by measuring the 
CEJ-ABC distance. Bacterial culture from oral swabs confirmed bacterial 
persistence. Differences were evaluated by ANOVA. 
Results: NBD-nanoparticles inhibit osteoclastogenesis directly and P. gingivalis-
induced pro-inflammatory cytokine production. NBD-nanoparticle application 
inhibits the gingival expression of periodontitis-related cytokines and alveolar bone 
loss in a murine ligature model. 
Conclusions: NBD-nanoparticle is able to inhibit osteoclastogenesis directly and 
pro-inflammatory cytokines production in vitro. This nanoparticle prevents gingival 
inflammation and bone loss in a murine model for periodontitis. 
Keywords: NBD-nanoparticles, NF-ĸB pathway, periodontal disease, 
osteoclastogenesis, inflammation, alveolar bone loss 
 vii 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS……………………………………………………………...iv 
ABSTRACT……………………………………………………………………………...v 
LIST OF FIGURES……………………………………………………………...…......ix 
Chapter 1: INTRODUCTION……………………………………………….................1 
1.1 Periodontitis…………………………………….……………………...1 
1.2 Periodontal disease and oral pathogens.…………………...………2 
1.3 Periodontal disease and Inflammation.……………………...……...4 
1.4 Periodontal disease and bone loss…..……………………...……....7 
1.5 NFκB Signaling pathway and Periodontal disease………………...8 
1.6 Periodontal pathogens, Porphyromonas gingivalis and NFκB 
Signaling pathway.………………………………….……….….…….9 
1.7 RANKL/RANK/OPG Pathway, NF-ĸB, and Osteoclastogenesis...…...15 
1.8 NF-ĸB pathway and Pro-inflammatory cytokines.….…….….……16 
1.9 NBD-nanoparticles.……………………………………………….….17 
Chapter 2: MATERIALS AND METHODS………………………………………..…20 
       2.1 Osteoclastogenesis…………………………...……….………….…20 
       2.2 Pro-inflammatory cytokines expression……………………………20 
       2.3 Murine ligature-induced periodontitis model………………………21 
       2.4 Quantification of cytokines.……………...………..…….………..…23
 viii 
       2.5 Morphometrical analysis of bone loss………………………...…...24 
       2.6 Statistical analysis........................................................................25 
 
Chapter 3: RESULTS………………………………………………………………….26
3.1 NBD-nanoparticle inhibits RANKL-induced osteoclastogenesis…….....…....26 
3.2 NBD-nanoparticle inhibits P. gingivalis-induced pro-inflammatory cytokine 
production...................................……………………………………………….……30 
3.3 NBD-nanoparticle treatment inhibits expression of periodontitis-related 
cytokines in gingiva…………………………………………………………..............34 
3.4 NBD-nanoparticle inhibits alveolar bone loss in a ligature model…………...37 




LIST OF FIGURES 
1. Tartrate resistant acid phosphatase positive (TRAP) Osteoclast..........................8 
2. NF-ĸB Protein family............................................................................................10 
3. Schematic depiction of the NF-κB pathway ........................................................11 
4. Canonical and Non-canonical pathways for the activation of NF-κB...................12 
5. The RANKL/RANK/OPG pathway for normal osteoclastogenesis......................15 
6. Illustration of Steps involved in the ligation procedure........................................21 
7. Schematic depiction of the protocol for periodontitis induction in vivo................22  
8. Illustration of the steps involved in the harvest of gingiva...................................23 
9. Picture of murine maxillary teeth showing the sites of measurement..............24 
10. NBD-nanoparticle inhibits RANKL-induced osteoclastogenesis.........................28 
11. NBD-nanoparticle inhibits RANKL-induced osteoclastogenesis.........................29 
12. NBD-nanoparticle inhibits P. gingivalis-induced pro-inflammatory cytokine 
production by human monocytes........................................................................32 
13. NBD-nanoparticle treatment inhibits expression of periodontitis-related cytokines 
by RAW cells. .....................................................................................................33 
14. NBD-nanoparticle treatment inhibits expression of periodontitis-related cytokines 
in vivo..................................................................................................................36 
15. Microscopic imaging of murine maxillary teeth depicting CEJ-ABC distance.....39 
16. Micro CT imaging of CEJ-ABC distance in murine maxillary teeth.....................37 




LIST OF TABLES 
 
 
1. Cytokines effect in inflammatory conditions..................................................6
  1 
CHAPTER 1:  INTRODUCTION 
Periodontitis, an inflammatory disease that results in a progressive loss of 
tooth-supporting bone, effects over 47% of the American adult population ranging 
from mild, moderate to severe forms of the disease (Eke et al., 2012). Destruction 
of tissue is pathognomonic of the disease which leads to gingival recession or 
periodontal pockets and the loss of alveolar bone. As a consequence of decreased 
tissue support around the tooth structure, mobility and eventual loss of tooth 
occurs. 
Epidemiological studies estimate that the disease affects 70% of the US adults 
aged 65 years or older (Papapanou, 2012). Globally, it affects 10-15% of the adult 
population according to WHO (Petersen & Ogawa, 2005).  Apart from being the 
most common chronic infection among adults, the treatment also imposes a huge 
economic burden globally (Loesche & Grossman, 2001). A study estimates that 
the projected cost could be over 1 billion dollars if only 10% of the periodontitis 
patients undergo periodontal therapy (Loesche & Grossman, 2001). Ironically, a 
majority of the people suffering from the disease belong to low-income groups and 
are unlikely to get the treatment done (Borrell & Crawford, 2012). 
The interaction between the plaque and the host is considered the primary 
etiological factor in the disease. The dental plaque contains a complex of multi-
bacterial species that together form a biofilm. Plaque if not removed mechanically 
on a regular basis, advances into a matured plaque, which consists of pathogenic 
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bacteria leading to dysbiotic changes. Dysbiosis, a state of impaired microbiota, is 
increasingly being acknowledged as a causative factor in many inflammatory 
diseases. This altered host-microbe cross-talk is also implicated in Periodontitis, 
the most common inflammatory disease of the oral cavity (Hajishengallis & 
Lamont, 2014). 
The periodontal disease, which is one of the main causes of tooth loss, was 
once thought to be a localized infection (Ahn et al., 2012; Southerland et al., 2005). 
However, it is now considered as a risk factor for some cardiovascular, respiratory, 
endocrine, musculoskeletal, and reproductive system related abnormalities by 
being a continuous source of infection (Arigbede et al., 2012; Yakob et al., 2012). 
 
Periodontal disease and oral pathogens: 
The oral cavity, which has a diverse ecosystem, is inhabited by a plethora 
of bacteria which is estimated to be around 700 species. However, not all the 
microorganisms are harmful as the disease is caused only by an increase in the 
abundance of specific microbes (Suzuki et al., 2013). Among the bacteria, 
Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, Tannerella 
forsythia (formerly Bacteroides forsythus), Porphyromonas gingivalis, Prevotella 
intermedia, Treponema denticola are important periodontal pathogens (Aruni et 
al., 2015) 
To explain the etiology of the biofilm-induced disease, many theories have 
been put forth based on the role of microorganisms in the initiation and progression 
of the disease. Specific microorganisms, non-specific plaque, specific plaque, red 
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complex, key stone pathogen, poly microbial synergy and dysbiosis are a few 
among them (Hajishengallis & Lamont, 2012). According to the red complex 
concept, a group of three species is associated with the severe forms of disease 
including Porphyromonas gingivalis, Treponema denticola and Tannerella 
forsythia (Socransky et al., 1998). Keystone pathogen theory postulates that the 
low abundance keystone microorganisms can disrupt the tissue homeostasis 
thereby causing tissue destruction (Hajishengallis et al., 2011). Porphyromonas 
gingivalis, one of the red complex organisms and a keystone pathogen has gained 
special attention partly because it is easy to culture and genetically manipulate 
(Hajishengallis & Lamont, 2012).  
 Although the etiology of periodontal disease is attributed to pathogenic 
microorganisms, the mere presence of periodontal pathogens does not cause 
tissue destruction by itself (Graves, 2008). Instead, the microorganisms involved 
in the pathogenesis of the disease act by modulating the host immune response 
(Reynolds et al., 2015). In other words, the bone loss in periodontitis is not just 
because of the invasion of the organism but a consequence of the pro-
inflammatory cytokines produced by the host in response to the pathogenic 
organism (Benedetto et al., 2013; Kato et al., 2014).  
 
Periodontal disease and Inflammation: 
Inflammation is a common physiological response to harmful stimuli such 
as a microbial challenge in this context. Initially, the disease starts as an 
inflammatory response affecting the gingiva, a condition known as gingivitis. 
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Removal of the harmful stimuli, the supra and subgingival plaque, at this stage 
leads to tissue homeostasis resulting in restoration of tissue health.  
However, the unremoved plaque coupled with factors such as poor oral hygiene, 
smoking, and other systemic conditions results in a shift from an acute stage to a 
chronic inflammation. The inflammation is a consequence of host responses to the 
persistent microbial encounter resulting from the unremoved plaque.  
 
Pro-inflammatory cytokines or simply inflammatory cytokines have 
repercussions on the periodontium as a result of tissue destruction and disease 
progression. On the other hand, anti-inflammatory cytokines are associated with 
the attenuation of disease. In general, the pro-inflammatory cytokines have a 
destructive role while the anti-inflammatory cytokines have a protective role 
(Garlet, 2010).  
 
Pro-inflammatory cytokines such as IL1-, IL-6, TNF are considered to 
be the pro-osteoclastogenic factors and contribute to the bone loss, along with 
Receptor activator of nuclear factor kappa-B ligand (RANKL) (Benedetto et al., 
2013; Kato et al., 2014). These cytokines destroy the periodontal tissue and 
result in the attachment loss of the gingiva causing either gingival recession or 
excessive periodontal pockets (Graves & Cochran, 2003). 
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Interleukins are a group of cytokines produced by leukocytes. Pro-
inflammatory cytokines responsible for the pathogenesis of the disease are 
explained briefly here. 
IL-1: 
Interleukin 1 is produced by activated mononuclear phagocytes and is produced 
in response to bacterial antigens and their products (Beuscher et al., 1990). There 
are two types of interleukin1; interluekin1, interleukin 1. Though the two 
subtypes of interleukin 1 bind to the same receptor, they have distinct functions. 
IL-1 is produced by blood monocytes, tissue macrophages, skin dendritic cells, 
and brain microglia. The precursor of IL-1 is inactive and it is activated by 
cleavage of caspase-1. The precursor is released in response to TLR, active 
complement proteins, cytokines and IL-1 itself (Garlanda et al., 2013). Studies 
have shown that IL-1, found in abundance in the crevicular fluid of gingiva, is a 
potent inducer of bone destruction and cause tissue destruction in inflammatory 
diseases including periodontitis (Hou et al., 1995; Hönig et al., 1989). 
IL-6: 
IL-6 is a pro-inflammatory cytokine, which has been found in the gingival crevicular 
fluid of periodontal patients. It plays a key role in acute inflammation and induces 
bone destruction (Graves, 2008). It is produced by B-lymphocytes, monocytes and 
macrophages, keratinocytes, endothelial cells, and fibroblasts. IL-6 is released in 
response to a stimulus such as bacteria or its products and other cytokines such 
as IL-1 and TNFα (Irwin & Myrillas, 1998). The pro-inflammatory cytokine aids in 
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IL-1β Bone resorption; pro-inflammatory; fever 
TNF-α 
Bone resorption; pro-inflammatory; fever; 
synergistic with IL-1β 
IL-6 
B-cell differentiation; antibody production; 
osteoclast differentiation 
 
Table 1. Cytokines effect in inflammatory conditions 
Reused from A clinical guide to periodontology: Pathology of periodontal disease Hasan 
& Palmer, British Dental Journal. 
 
TNFα: 
Tissue necrosis factor  is considered one of the most potent cytokines which 
induces osteoclastogenesis in inflammatory conditions such as rheumatoid 
arthritis, orthopedic implant loosening, periodontitis and other chronic inflammatory 
osteolytic diseases (Garlet, 2010; Lam et al., 2000; Zhang et al., 2001). TNFα has 
been confirmed to upregulate the other cytokines such as IL-1β and IL-6 and has 
been found in abundance in the gingival crevicular fluid (Benedetto et al., 2013; 
Garlet, 2010). TNFα acts in the progression of the periodontal disease by multiple 
mechanisms such as expression of chemokines, inflammatory mediators, matrix 
metalloproteinases, osteoclastogenesis, and apoptosis of matrix-producing cells 
(Graves & Cochran, 2003). 
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In summary, these pro-inflammatory cytokines break down the tissue causing 
attachment loss and bone resorption. 
Periodontal disease and bone loss: 
Alveolar bone loss in periodontitis is the main factor including attachment loss, 
which is responsible for tooth mobility or even loss of the tooth. Bone loss is caused 
by the osteoclasts by bone resorption. On the other hand, osteoblasts are the cells 
that help in the bone deposition. In fact, the action of both osteoblasts and 
osteoclasts is necessary for normal development, remodeling and functioning of 
an organism. In health, the osteoblastic and osteoclastic activity are in a balanced 
state where the amount of bone resorption equals the amount of deposition 
resulting in a healthy maintenance of bone (Hienz et al., 2015). 
Osteoclastogenesis is the development of the bone resorbing cells, the 
Osteoclasts. Osteoclasts are terminally differentiated large cells with multiple 
nuclei and originate from mononuclear cells of the hematopoietic stem cell lineage 
(Florencio-Silva et al., 2015). Their unique structure consists of a ruffled border 
seen on the cell surface that helps in secretion of enzymes as well as uptake of 
matrix components. A Clear zone is seen encircling the ruffled border and helps in 
resorption (Teti et al., 1991). Vacuoles and vesicles help in secretion of enzymes, 
digestion or transport of products within the cell (Holtrop & King, 1977). 
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Figure 1: Tartrate resistant acid phosphatase positive (TRAP) Osteoclast 
       Arrow indicates the TRAP-positive cell: osteoclast. 
 
The lysosomes contain large amounts of Tartrate-resistant acid phosphatase 
(TRAP) and is a useful cytochemical marker (Ballanti et al., 1997). Excessive 
osteoclastogenesis shifts the balance in favor of extensive bone loss as seen in 
periodontitis. 
 
NFκB Signaling pathway and Periodontal disease: 
NF-ĸB (Nuclear factor kappa-light-chain-enhancer of activated B cells) signaling 
pathway is critical in osteoclastogenesis and infection-induced pro-inflammatory 
responses for being at the juncture of diverse signaling pathways (Abu-Amer, 
2013; Lawrence, 2009). Blocking this pathway has become an attractive target in 
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inflammatory diseases such as cancer and chronic inflammatory diseases and is 
possible with Nemo Binding Domain (NBD) inhibitory peptide (Pan et al., 2011).  
NF-ĸB consists of transcription factors which are pivotal in cellular growth and 
development, regulating immune and inflammatory responses, and apoptosis 
(Oeckinghaus & Ghosh, 2009). These factors are responsible for a number of 
disease states such as atherosclerosis, heart disease, rheumatoid arthritis, cancer 
and also Periodontitis (Nichols et al., 2001; Okamoto, 2006; Ross et al., 2001; 
Valen et al., 2001; Gilmore et al., 2002). 
 
The NF-ĸB protein family is divided into two subfamilies: the ‘’NF-ĸB’’ proteins and 
‘’Rel’’ proteins. NF-ĸB proteins include p105, p100. The Rel subfamily includes c-
Rel, RelB, RelA (aka p65). Rel proteins contain C-terminal transactivation domains 
and can activate transcription. Long C- terminal domains with multiple copies of 
Ankyrin repeats on the NF-ĸB subfamily of proteins make them inactive. These 
proteins become short to get active by either limited proteolysis or arrested 
translation (p105 to p50 and p100 to p52). This necessitates NF-ĸB subfamily to 
form dimers with members of the Rel subfamily to activate transcription (Gilmore, 
2006). The active form of NF-ĸB is thus a heterodimer consisting p65 and p50 
subunits (Barnes & Karin, 1997). 
 
As the NF-ĸB pathway is involved in many important cellular responses, its tight 
regulation is justified. This is done by the interaction with the inhibitory proteins 
IkB such as IkBα, IkB β, IkB γ, IkB ē which have different affinities for individual 
  10 
NF-ĸB dimers. As such, in most of the cells, NF-ĸB is present in an inactive form 
in the cytoplasm along with IkB protein (Oeckinghaus & Ghosh, 2009). The NF-
ĸB signaling is activated by a stimulus, bacteria/bacterial products in this 
circumstance. The activation of NF-ĸB requires IKKα, IKKβ and the regulatory 
protein NF-ĸB essential modifier IKK γ (or NEMO) which together constitute the 
IKK complex (Hacker & Karin, 2006).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 
Figure 2: The NF-ĸB Protein family 
Image showing the classification of mammalian NF-ĸB proteins. 
 
The IKK complex phosphorylates IKB leading to ubiquitination and degradation. 
NF-ĸB which is now free can translocate into the nucleus where it initiates 
transcription (Oeckinghaus & Ghosh, 2009). 
 
NF-ĸB activation can occur by two main pathways: Canonical or classical and non-
canonical pathway. Recent studies show that the canonical and the non-canonical 
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pathway are involved in innate immunity and adaptive immunity respectively 
(Bonizzi & Karin, 2004). 
 
  
Figure 3: Schematic depiction of the NF-κB pathway 
The image depicts the mechanism of pro-inflammatory cytokine production and 
osteoclastogenesis through activation of NF-ĸB. 
 
The classical pathway can be stimulated by cytokines such as TNFα, interleukin 1 
(IL-1), antigens and toll-like receptors (TLR4). It is mainly concerned with the 
phosphorylation of IkB α and is dependent on IKKβ and IKK of the IKK complex, 
resulting in the translocation of P65 protein heterodimers (Hayden & Ghosh, 2004; 
Oeckinghaus et al., 2011).  
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Figure 4: Canonical (Left) and Non-canonical (Right) Pathways for the 
Activation of  
NF-κB 
 
Figure reused with permission from Elsevier, Molecular cell, Two Pathways to NF-κB, 
Pomerantz, Baltimore, October 2002. 
 
On the other hand, the non-canonical pathway is induced by specific TNF 
cytokines such as CD40 ligand, BAFF, and lymphotoxin-β except TNF (Bonizzi 
& Karin, 2004; Oeckinghaus et al., 2011). It is dependent on IKKα-mediated 
phosphorylation of P100- RelB, resulting in the formation of p52-RelB complexes 
(Hayden & Ghosh, 2004). 
 
 The NF-ĸB pathway is important in pro-inflammatory signaling through the 
production of cytokines, chemokines, and adhesion molecules (Lawrence, 2009). 
In addition, NF-ĸB signaling transduction is pivotal in the downstream of 
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RANK/RANKL pathway that leads to the development of osteoclasts (Yamaguchi 
et al., 2012).  
 
Periodontal pathogens, Porphyromonas gingivalis, and NFκB Signaling pathway: 
Bacteria, bacterial products, and viruses are known to be the inducers of NF-ĸB, 
which controls of transcription of around 150 target genes (Pahl, 1999). Among the 
bacteria, Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, 
Tannerella forsythia (formerly Bacteroides forsythus), Porphyromonas gingivalis, 
Prevotella intermedia, Treponema denticola are important periodontal pathogens 
and are known to be inducers of NF-ĸB  (Kobayashi-Sakamoto et al., 2004; Walter 
et al., 2004; Hasebe et al., 2004; Huang et al., 2004; Kim et al., 2004; Tanabe et 
al., 2008; Tiranathanagul et al., 2004). Also, bacterial lipopolysaccharide (LPS) 
has been shown to activate NF-ĸB signaling pathway (Sen & Baltimore, 1986). 
 
Porphyromonas gingivalis is one of the major etiological organisms in the 
pathogenesis of the periodontal disease that is also known to be an inducer of the 
NF-ĸB (Groeger et al., 2017; Lamont & Jenkinson, 1998). Studies have shown that 
LPS, one of the major constituent of the outer membrane of Porphyromonas 
gingivalis, induces NF-ĸB (Ding et al., 2013). Also, studies have found that the 
activation of NF-kB by P. gingivalis is through IkB kinase (IKK) complex (Carayol 
et al., 2006). In addition, IKK , the regulatory protein is essential for the activation 
of IKK complex in inflammation (May et al., 2000). 
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 LPS consists of three parts: lipid A, a core oligosaccharide, and an O side chain 
(Raetz & Whitfield, 2002). Pathogen-associated molecular patterns (PAMPs) are 
structures within a class of microbes that are recognized by pattern recognition 
receptors (PRRs) present on the cells of innate immunity system (Mogensen, 
2009). Lipid A of LPS is the main PAMP that is recognized by toll-like receptors, a 
pattern recognition receptor (PRR). The LPS binds to toll-like receptors, mainly 
TLR4 and upregulates the expression of nuclear factor-κB (NF-κB) (Wang et al., 
2000). Activation of NF-ĸB signaling pathway by Porphyromonas gingivalis leads 
to the production of pro-inflammatory cytokines particularly interleukin-1β (IL-1β), 
tumor necrosis factor-α (TNF-α) and IL-6 and osteoclastogenesis (Choi et al., 
2005) (Diya et al., 2008). 
 
RANKL/RANK/OPG Pathway, NF-ĸB, and Osteoclastogenesis: 
Many factors such as macrophage colony- stimulating factor (M-CSF), Receptor 
activator of nuclear factor kappa-B ligand (RANKL) influence the formation of 
osteoclasts the RANKL/RANK/OPG Pathway which is upstream of the NF-ĸB 
signaling cascade. 
NF-ĸB pathway is downstream of RANKL/RANK pathway and it is now established 
that this pathway is critical and essential for osteoclastogenesis (Boyce, 2013). 
RANKL, a member of TNF family, is a homotrimeric transmembrane protein 
secreted by osteoblasts and stromal cells (Nelson et al., 2012). It is expressed in 
bone and bone marrow, lymph nodes, thymus, spleen, mammary glands and the 
brain (Liu & Zhang, 2015). 
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Figure 5: The RANKL/RANK/OPG pathway for normal osteoclastogenesis. 
Picture reused with permission from Dr. Brendan F Boyce, Biology of RANK, RANKL, and 
Osteoprotegerin, Arthritis Research & Therapy2007 
 
In Rheumatoid arthritis, RANKL is highly expressed and appears to be responsible 
for the destruction of tissue at the joint (Geusens, 2012). Binding of RANKL to its 
receptor RANK on osteoclast precursors leads to the formation of osteoclasts 
(Khosla, 2001). To counteract the production of osteoclasts, a factor called 
osteoprotegerin (OPG) is produced which binds to RANKL, thus acting as a decoy 
receptor and inhibiting the osteoclastogenesis.  
Receptor activator of NF-κB (RANK) is a member of tumor necrosis factor receptor 
(TNFR) family and a type 1 homotrimeric transmembrane protein present in normal 
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cells, mammary glands and in some cancer cells (Boyce & Xing, 2007). RANKL 
binds to its receptor RANK resulting in osteoclastogenesis via activation of NF-ĸB. 
RANKL/RANK/OPG axis is hence considered the central controller of the 
osteoclastogenesis and function (Florencio-Silva et al., 2015; Kobayashi, 
Udagawa, & Takahashi, 2009). 
 
NF-ĸB pathway and Pro-inflammatory cytokines: 
A coordinate regulation of the signaling pathways that regulate the expression of 
pro-inflammatory and anti-inflammatory cytokines is necessary to maintain 
health. This is because excessive production of pro-inflammatory cytokines 
drives the tissue in favor of destruction. The significance of NF-ĸB pathway in the 
expression of pro-inflammatory genes has been well-documented (Lawrence, 
2009). These pro-inflammatory genes are responsible for the expression of 
cytokines, chemokines, and adhesion molecules. Although cytokines produced 
act independently, there is an associated crosstalk with other cytokines. NFκB 
signaling pathway exhibits a broad control over the network and cascade of 
cytokines by regulating the genes involved in the production of cytokines. 
As previously mentioned, current evidence suggests that the pro-inflammatory 
cytokines such as IL1-, IL-6, TNF contribute to the tissue destruction and bone 
loss in periodontal disease (Benedetto et al., 2013; Kato et al., 2014; Graves & 
Cochran, 2003). Furthermore, the periodontal pathogens Actinomycetes 
actinomycetemcomitans and P. gingivalis have been shown to induce the 
production of IL-1β, TNF-α, IL-6 through NFκB pathway (Kayal, 2013). NF-ĸB 
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pathway is critical in the expression of cytokine genes involved in the 
pathogenesis of periodontitis: IL-1 , IL-6, and TNF (Cogswell et al., 1994) 
(Libermann & Baltimore, 1990; Liu et al., 2000). Hence, the NF-ĸB pathway 
which includes both the canonical and the non-canonical pathway can be 
described as the “mastermind” in the regulation of these pro-inflammatory 
cytokines which are critical in the pathogenesis of periodontal disease. 
 
NBD-nanoparticles:  
Many authors have described this labyrinthine pathway as a “holy grail” of targeting 
the pathway for therapeutic purposes (Firestein, 2004; Lawrence, 2009). One of 
the approaches is to block the pathway with the help of an NBD peptide. The 
NEMO binding domain (NBD) peptide is shown to effectively block the association 
of NEMO with IKK complex thereby inhibiting NF-ĸB activation. This peptide 
targets only the inflammation induced NF-ĸB activity, while sparing the protective 
functions of basal NF-ĸB activity displaying fewer undesired side effects (Strickland 
& Ghosh, 2006). Also, the traditional lipid bilayer system is ineffective in drug 
delivery as the peptides are subjected to rapid protease degradation and limited 
bioavailability due to their inability to pass through the cell membrane. The peptide 
is incorporated into the outer lipid monolayer of the stable perfluorocarbon 
nanoparticle system for effective drug delivery that ensures inhibition of NF-ĸB but 
not complete suppression (Pan et al., 2011b).  
The use of nanoparticles increases stability, loading capacity, and facilitates 
transmembrane transportation of the drug. The efficacy of the NBD-nanoparticles 
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in inhibiting bone loss in relation to periodontitis has not been tested to date. The 
current treatment procedures for periodontitis are expensive, unaffordable by 
those who require the treatment the most and require long-term maintenance by 
the patients to be effective. The NBD-nanoparticles may prove to be a novel 
therapeutic drug treating the disease more effectively, thus reducing the severity 
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HYPOTHESIS 
We hypothesized that the NBD-nanoparticles can lead directly to inhibition of 
osteoclastogenesis and pro-inflammatory cytokines production in vitro. We also 
hypothesized that this nanoparticle inhibits gingival inflammation and prevents 
bone loss in a murine model for periodontitis. 
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CHAPTER 2: MATERIALS AND METHODS 
In vitro experiments: 
Osteoclastogenesis: 
RAW 264.7 cells (ATCC CLR-2278) were cultured (103 cells) in a 96 well plate in 
α-MEM supplemented with 10% FBS and 100ng/ml murine soluble RANKL 
(sRANKL) (Peprotech®). Nanoparticles of different dosages were added into the 
cell culture (120, 600, 1200 and 2400 pM). Five days later, the cells were stained 
for the enzyme tartrate-resistant acid phosphatase (TRAP) using the Leukocyte 
Acid Phosphatase TRAP Kit (Sigma-Aldrich®). The number of multinucleated 
TRAP-positive cells were counted which represent the multinucleated osteoclasts. 
(Jacome-Galarza et al., 2013). NBD-nanoparticles and nanoparticles were 
obtained from Washington University at St. Louis in collaboration with the 
laboratories of Dr. Samuel A. Wickline and Dr. Hua Pan. 
 
Pro-inflammatory cytokines expression: 
The RAW 264.7 cells (ATCC CLR-2278) and THP 1 cells (Invivogen) were 
separately stimulated with P. gingivalis 33277 (ATCC®) at MOI of 10:1 overnight. 
Cells were treated with different dosages of nanoparticles (120, 600, 1200 and 
2400 pM) along with P. gingivalis 33277 (ATCC®). The culture supernatant was 
harvested after incubating overnight. The cytokine expression of IL-1β, IL-6, and 
TNFα was measured by enzyme linked immunosorbent assay (ELISA).  
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In vivo Experiments: 
Murine ligature induced periodontitis model: 
Mice received a ligature around the second molar, placed in the gingival sulcus.    
(Abe & Hajishengallis, 2013). The ligature-induced periodontitis model is a 
preferred method as it drastically reduces the time to develop periodontitis and by 
exaggerating inflammation and bone loss (Molon et al., 2014; Oz & Puleo, 2011). 
 
Figure 6: illustration of Steps involved in the ligation procedure 
Picture reused with permission from Journal of Immunological Methods, Abe & 
Hajishengallis, (2013). Optimization of the ligature-induced periodontitis model in mice. 
 
A) 5–0 silk suture was passed in between the second molar and third molar using Dumont 
forceps. (B) Suture was passed through between first molar and second molar using 
Dumont forceps. (C) Suture was looped around the second molar (taking care to remove 
the slack) using suture-tying forceps. (D) Suture was tied firmly using a triple-knot and 
excess suture was cut using spring scissors. 
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The mice were infected with 1 x 109 colony-forming units of P. gingivalis (3327; 
American Type Culture) or 2% carboxymethylcellulose vehicle as a control every 
other day for 3 times. Immediately after the ligation, micro-injections of 10μl of 1.2 
nM NBD-Nanoparticles, nanoparticles or phosphate buffer solution (PBS) was 











Figure 7. Schematic depiction of the protocol for periodontitis induction in 
vivo.  
On the first, third and fifth day of ligation, microinjections of NBD- nanoparticles, 
nanoparticles or phosphate buffer solution (PBS) was given in the palatal gingiva between 
first and second molars. Additionally, they were infected with P. gingivalis on days 1, 3, 




Pg Infection 1,3,5 
8 
Numbers indicate Days 
LIGATION 
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Gingiva harvest and quantification of cytokines:  





Figure 8: Illustration of the steps involved in the harvest of gingiva. 
Incision ①, ②, ③ were made first. The red triangle part of the gingiva was grasped and 
the lingual part of gingiva was pulled. Then, incision ④ was made and the black part of 
the gingiva grasped and the buccal part of the gingiva pulled. 
 
RNA was isolated using RNeasy kit (Qiagen). RNA was reversed-transcribed and 
mRNA expression of cytokines - IL-1β, IL-6, TNFα, and RANKL was determined 






②  ②  ③  ③  ④  ④  
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Jaw harvest and Morphometrical analysis: 
The skulls were subjected to boiling at 15psi for 10 minutes. After defleshing, the 
maxillae were separated from the skulls. Maxillae were cleaned with gentle 
brushing followed by bleaching overnight. Later, they were stained with 0.5% eosin 
and 1% methylene blue (Abe & Hajishengallis, 2013). Alveolar bone heights were 
assessed using a 40 X objective under a Nikon SMZ800 microscope (Nikon 
Instruments Inc., NY, USA).  
 
Figure 9: Picture of mice maxillary teeth showing the sites of measurement. 
Arrows indicate the site of measurement. Measurements were taken at six different sites- 
the mesial cusp, buccal groove and distal cusp of the first molar, the mesial cusp and distal 
cusp of the 2nd molar, and buccal cusp of the third molar. 
 
Bone heights were measured morphometrically and the images of the maxillae 
were captured using a Nikon Digital Sight DS-U3 camera controller (Nikon 
Instruments Inc.). Measurements were taken at six different sites- the mesial cusp, 
buccal groove and distal cusp of the first molar, the mesial cusp and distal cusp of 
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the 2nd molar, and buccal cusp of the third molar. The readings of CEJ-ABC 
distance at each site were totaled for each mouse. Bone loss was calculated by 
subtracting the six-site total CEJ-ABC distance for the ligated mice from the six-
site total CEJ-ABC distance of the unligated mice. Micro-CT was performed in the 
Department of Radiology at University of Louisville. 
 
Statistical analysis:  
Data were evaluated by ANOVA (InStat v3.06 program, GraphPad) and 
differences were considered significant at the p < 0.05 level. 
 
Human Subjects: No human subjects were used in the experiment. 
 
Vertebrate Animals: C57BL6 mice were purchased from the Jackson laboratory. 
All experimental procedures were performed in accordance with the guidelines of 
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CHAPTER 3: RESULTS 
The overall strategy of this research is to investigate the ability of NBD-
nanoparticles to directly inhibit osteoclastogenesis, and the pro-inflammatory 
cytokine response to a bacterial stimulus using in vitro studies. Also, to investigate 
the therapeutic ability of NBD-nanoparticles to inhibit pro-inflammatory cytokine 
production in the gingiva and reduce alveolar bone loss in a murine ligature 
induced periodontitis model. 
 
1) NBD-nanoparticle inhibits RANKL-induced osteoclastogenesis: 
Bone loss in periodontitis is a result of an imbalance in the osteoblastic and 
osteoclastic activity. Since the current evidence attributes the bone loss to 
osteoclastogenesis through the NF-ĸB pathway that is downstream of 
RANKL/RANK pathway, we first investigated whether the NBD-nanoparticle can 
prevent the RANKL-induced osteoclastogenesis in vitro. 
 
Since osteoclasts are derived from monocyte precursors, we used the RAW cell 
line cells which are murine monocyte/macrophages. Furthermore, RAW cells are 
the most extensively used cell line for decades to study the differentiation of 
osteoclasts (Collin-Osdoby et al., 2003; Jacome-Galarza et al., 2013). 
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In order to test the ability of NBD-nanoparticles to prevent RANKL-induced 
osteoclastogenesis, we examined the cells through microscopy, and osteoclastic 
cell formation was determined by the number of multinucleated TRAP positive 
cells. Cells with three or more nuclei were considered  to be osteoclasts. Controls 
included treatment with empty nanoparticles and no treatment. Cells with no 
stimulation (RANKL) were also used. 
 
In the cells without RANKL-stimulation and with or without NBD nanoparticle 
treatment, there were virtually no TRAP-positive cells indicating that RANKL is 
required for differentiation into osteoclasts. As expected, the cells incubated with 
RANKL stimulated the formation of a large number of TRAP positive cells. This 
indicates a crucial role of RANKL in initiating the RANKL/RANK pathway towards 
osteoclastogenesis. After we treated the RAW cells with NBD-nanoparticles, the 
formation of TRAP positive cells was significantly reduced (Fig 10, 11), while the 
empty nanoparticles without NBD did not inhibit osteoclastogenesis (Fig 10). We 
further counted the number of osteoclasts in each well. Our results showed that 





















Figure 10. NBD-nanoparticle inhibits RANKL-induced osteoclastogenesis: 
RAW 264.7 cells were treated with RANKL and 2.4µM of NBD-nanoparticles (NBD-
NP) or Nanoparticles (NP). Untreated cells (RANKL) or empty Nanoparticle (NP) 
treated cells were used as controls. The cells were cultured for 5 days and stained 














Figure 11. NBD-nanoparticle inhibits RANKL-induced osteoclastogenesis. 
RAW 264.7 cells were treated with RANKL and 2.4µM of NBD-nanoparticles (NBD-
NP). Untreated (RANKL only) and empty nanoparticle treated cells were used as 
controls. The cells were cultured for 5 days and stained with TRAP. The 
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2. NBD-nanoparticle inhibits P. gingivalis-induced pro-inflammatory 
cytokine production: 
It has already been reported that the NF-ĸB pathway is critical in the infection-
induced pro-inflammatory cytokine production. Moreover, considering the role of 
inflammatory cytokines in the destruction of tooth supporting tissue in periodontitis, 
we wanted to examine if NBD-nanoparticles will inhibit infection- induced pro-
inflammatory cytokine expression relevant to periodontitis- IL-1β, IL-6 and TNFα.  
 
For measuring the expression of IL-1β, IL-6 and TNFα by ELISA, either RAW cells 
or THP1 cells were incubated overnight and the supernatant was harvested. The 
cells that did not stimulated with P. gingivalis showed nearly negligible amounts of 
IL-1β, suggesting that there was no NF-ĸB activation in the absence of infection. 
In contrast, a dose dependent significant decrease in the amount of IL-1β was 
noted in the cells that received NBD-nanoparticle treatment. At a treatment dose 
of 2.4 µM of NBD nanoparticles, the amount of IL-1β was almost equivalent to the 
unstimulated cells. This data confirms that the NBD-nanoparticles effectively block 
the production of IL-1β (Fig.12). 
 
Furthermore, cells expressed IL-6 responding to P. gingivalis stimulation, while the 
amount of IL-6 was significantly reduced in the NBD-nanoparticle-treated human 
monocyte cells. A dose-dependent decrease was observed from 0.6 to 1.2 µM 
NBD-nanoparticles (Fig.12). Similarly, in murine macrophage cells, a small amount 
of IL-6 expression was observed in the unstimulated cells treated with the empty 
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nanoparticle (Fig. 13). The amount of IL-6 after treatment with NBD-nanoparticles 
decreased to the level of unstimulated cells confirming that the NBD-nanoparticle 
is capable of inhibiting the IL-6 production in vitro (Fig. 13). 
Next, we investigated the expression of TNFα in murine macrophage cell line for 
testing the efficacy of NBD-nanoparticles. Data showed that the unstimulated cells 
only produce tiny amount of TNFα. Not surprisingly, P. gingivalis stimulation 
induced TNFα production. Our data indicate a dosage-dependent decrease in the 
TNFα levels after treatment with NBD-nanoparticles in P. gingivalis-infected cells 
(Fig.13). This suggests that the NBD-nanoparticle is effective in suppressing TNFα 
production. 
 
In summary, our results corroborate that the NBD-nanoparticles are able to inhibit 
the infection-induced production of IL-1β, IL-6 and TNFα, which are important 




















Figure 12. NBD-nanoparticle inhibits P. gingivalis-induced pro-inflammatory 
cytokine production by human monocytes: THP1 cells were treated with 
different dosages (0.6, 1.2, and 2.4µM) of NBD-nanoparticles (NBD) at the time of 
P. gingivalis (Pg) infection (MOI 10:1). The cells without stimulation (NS) were 
used as controls. The cells were cultured overnight and supernatant were tested 
for production of (A) IL-1 and (B) IL-6. Data presented as mean ± SD (n = 3). 
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Fig. 13. NBD-nanoparticle inhibits P. gingivalis-induced pro-inflammatory 
cytokine production by RAW cells. RAW cells were treated with different 
dosages of NBD-nanoparticles (NBD) at the time of P. gingivalis (Pg) infection 
(MOI 10:1).  The cells were cultured overnight and supernatant were tested for 
production of (A) TNFα and (B) IL-6. * p<0.05，**：p<0.01 
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In vivo experiments: 
The overall strategy of the in vivo experiments is to determine the ability of NBD-
nanoparticles to effectively control the inflammation and inhibit alveolar bone loss. 
For this purpose, a murine ligature-induced Periodontitis model was used (Abe & 
Hajishengallis, 2013). 
 
3. NBD-nanoparticle treatment inhibits expression of periodontitis-related 
cytokines:  
We have established that the NBD-nanoparticle can inhibit inflammatory cytokine 
production in vitro. In addition, literature provides evidence that the production of 
pro-inflammatory cytokines via NF-ĸB activation as a host response to the 
microbial attack leads to tissue destruction in periodontitis. So, we wanted to 
investigate the NBD-nanoparticle’s ability to inhibit inflammation in vivo using a 
murine ligature-induced periodontitis model.  
C57/BL6 mice were ligated and received micro-injections of NBD-nanoparticles. 
Additionally, the ligated mice were infected with P. gingivalis three times every 
other day. Controls included  
ligated mice treated with empty nanoparticles or no treatment. On day 8, the mice 
gingivae were harvested and tested for expression of cytokines, including RANKL, 
IL-1β, IL-6 and IL-17 by quantitative RT-PCR. 
 
Our results demonstrated a high level of expression of RANKL, IL-1β and IL-6 
except IL-17 in the untreated mice (Fig. 14). Furthermore, the empty nanoparticle 
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treated mice had no significant difference in the expression levels from the 
untreated mice, although IL-17 relative levels were increased after treatment with 
empty nanoparticles. Nonetheless, literature suggests a controversial dual role of 
IL-17 in protection and progression of inflammatory diseases (Miossec et al., 2009; 
Yu et al., 2007). However, the NBD-nanoparticle seemed to have a consistent 
suppressive effect on all the tested cytokines, which is indicated by the decreased 
relative levels of expression.  
 
These data show that NF-ĸB inhibition by the NBD nanoparticle results in a 
decreased expression of cytokines – RANKL, IL-1β, IL-17 and IL-6 in the gingiva. 
In addition, these results indicate that the NBD-nanoparticle is able to inhibit 
















Figure 14. NBD-nanoparticle treatment inhibits expression of periodontitis-
related cytokines. Relative expression of pro-inflammatory cytokines in the 
gingivae of mice treated with NBD-nanoparticle (NBD-NP), empty nanoparticles 
(NP), or without treatment (UT). Quantitative real-time PCR (qPCR) was used to 
determine gingival mRNA expression levels for the indicated molecules 
(normalized against GAPDH mRNA levels). The gingivae used were excised from 
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C57/BL6 mice. Results are shown as fold change relative to sham-ligated mice, 
respectively. Each data point represents the mean ± SD of 5 separate expression 
values, each value corresponding to qPCR analysis of an individual mouse. 
Asterisks indicate statistically significant (p < 0.05) differences between NBD-
nanoparticle treated mice and other groups. 
4. NBD-nanoparticle inhibits alveolar bone loss in a ligature model: 
As we have demonstrated that the NBD-nanoparticle is capable of inhibiting the 
formation of the bone resorbing cells (osteoclasts) in vitro, we were interested in 
investigating if the nanoparticle can block the NF-ĸB activation-induced 
osteoclastogenesis leading to less severe bone loss. Thus, to examine the ability 
of NBD-nanoparticles to inhibit alveolar bone loss, a murine ligature-induced 
periodontitis model is used as previously described. Microinjections of NBD-
nanoparticles, nanoparticles or PBS was done. In addition, they were infected with 
P. gingivalis every other day for 3 times. Control mice had sham-ligature and 
sham-infection. Seven days’ post ligation, the mice were euthanized and the skulls 
were harvested. Measurement of CEJ- ABC distance was done morphometrically 
with the help of microscopy (Fig.15) and Micro-CT scan (Fig. 16) at six different 
sites.  
 
Our results showed that there was no significant difference in the CEJ-ABC 
distance in the non-ligated group. Conversely, the ligated mice treated with empty 
nanoparticles or no treatment exhibited more CEJ-ABC distance. However, the 
NBD-nanoparticle treated mice showed a lesser CEJ-ABC measurement. 
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Subsequently, we determined the bone loss, which was obtained by subtracting 
the total CEJ-ABC distance of ligated to that of unligated mice (Fig. 17). Our results 
demonstrated that the bone loss was significantly reduced after treatment with the 
NBD-nanoparticles when compared to that of sham mice. 
These results indicate that the NBD-nanoparticles markedly reduced the bone loss 
in a murine ligature induced periodontitis model. This observation supports our 
hypothesis that the NBD-nanoparticles through inhibition of NF-ĸB pathway 





















Figure 15. NBD-nanoparticle inhibits alveolar bone loss in a ligature model: 
 C57Bl/6 mice were ligated around 2nd molar to induce bone loss. The mice were 
treated with NBD-NP, empty NP, or left untreated. The mm distance from the 
cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) was measured 
at 6 most affected maxillary buccal sites and the readings were totaled for each 
mouse. Pictures were captured using a Nikon Digital Sight DS-U3 camera 
controller (Nikon Instruments Inc.) 
 
 








Figure 16. NBD-nanoparticle inhibits alveolar bone loss in a ligature model: 
 C57Bl/6 mice were ligated around 2nd molar to induce bone loss. The mice were 
treated with NBD-NP, empty NP, or left untreated. The mm distance from the 
cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) was measured 
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Figure 17. NBD-nanoparticle inhibits alveolar bone loss in a ligature model. 
C57Bl/6 mice were ligated around 2nd molar to induce bone loss. The mice were 
treated with NBD-NP, empty NP, or left untreated. The mm distance from the 
cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) was measured 
at 6 most affected maxillary buccal sites and the readings were totaled for each 
mouse. The data are means ± SD (n = 7 for untreated ligated and non-ligated, 9 
for NP ligated and non-ligated, 10 for NBD-NP ligated and non-ligated  mice). The 
CEJ-ABC reading of each mouse was represented by each dot. Bone loss was 
calculated by subtracting the six-site total CEJ-ABC distance for the ligated mice 
from the six-site total CEJ-ABC distance of the unligated mice. Asterisks indicate 
statistically significant (p < 0.05) differences between NBD-NP treated and other 
groups. 
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CHAPTER 4: DISCUSSION 
Periodontitis is characterized by both gingival inflammation and alveolar bone loss. 
NF-ĸB signaling pathway is pivotal in osteoclastogenesis and infection-induced 
pro-inflammatory responses for being at the crossroad of a variety of signaling 
pathways. Porphyromonas gingivalis (P. gingivalis) is one of the most important 
and widely investigated periodontal disease etiological pathogens. Reasons for a 
being an extensively studied organism in periodontitis might range from being a 
key stone pathogen, member of red complex, persistence of the species in 
periodontal patients to easy culture methods and genetic manipulation. In addition, 
inoculation of P. gingivalis in animals induces gingival inflammation and alveolar 
bone loss. Because of their critical role in host immune responses, NF-ĸB must be 
tightly regulated to avoid excessive or defective immune responses. Many authors 
have described NF-ĸB as “holy grail”, “master switch”, “master regulator”, “center 
piece” of inflammatory responses (Abu-Amer, 2013; Firestein, 2004; Lawrence, 
2009). As the evidence shows NF-ĸB to be a key player in the inflammation, the 
pathway has been a therapeutic target for many researchers.  
 
A nanoparticle cargo carrier undergoing FDA-approved clinical trials has been 
linked with therapeutic peptide, Nemo Binding Domain (NBD) inhibitory peptide, 
which prevents NF-ĸB activation. A peptide-nanoparticle complex is formed and 
inhibition of NF-ĸB signaling has been demonstrated. We hypothesized that 
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the NBD-nanoparticles can lead to inhibition of osteoclastogenesis directly and 
pro-inflammatory cytokines production in vitro. We also hypothesized that this 
nanoparticle inhibits gingival inflammation and prevents bone loss in a murine 
model for periodontitis. 
 
A right balance between the bone forming osteoblasts and bone resorbing 
osteoclasts is of utmost importance for the bone homeostasis and maintenance. 
When the balance tips towards formation of excessive osteoclasts, it results in 
bone resorption. Because periodontal disease is characterized by bone loss and 
the NF-ĸB activation leads to formation of bone resorbing cells, we wanted to 
establish the ability of the NBD-nanoparticles to prevent RANKL-induced 
osteoclastogenesis. Our results demonstrated a decrease in the number of TRAP-
positive cells after treatment with the NBD-nanoparticles confirming that the NBD-
nanoparticle is able to inhibit RANKL-induced osteoclastogenesis by blocking the 
NF-ĸB pathway (Fig.11). Furthermore, we wanted to investigate the ability of this 
nanoparticle to inhibit pro-inflammatory cytokine production. Since, periodontal 
disease is a repercussion of chronic inflammation and the NF-ĸB pathway has a 
central role in the production of cytokines especially those that are implicated in 
periodontitis, we examined the expression of these cytokines- IL-1β, IL-6 and 
TNFα (Fig. 12,13). Our data showed a marked reduction in the levels of cytokines 
and suggested that the NBD-nanoparticles are effective in inhibiting the pro-
inflammatory cytokine production by blocking the NF-ĸB. 
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After establishing the action of NBD-nanoparticles in a set of in vitro experiments, 
we studied the ability of these nanoparticles in vivo. For this purpose, we used a 
murine ligature-induced periodontitis model and additionally infected them with P. 
gingivalis to exacerbate the gingival inflammation. Our results were consistent with 
the in vitro experiment data and demonstrated a decrease in the expression of 
inflammatory cytokines important in the pathogenesis of the periodontal disease 
(Fig. 14). Similarly, the NBD-nanoparticle treated group showed less CEJ-ABC 
distance when compared to the untreated (Fig. 17). This data suggests that the 
nanoparticles are effective in inhibiting gingival inflammation and alveolar bone 
loss in a murine ligature-induced periodontitis model. 
 
 Normally, in response to an infection, the IKK complex is activated by the 
binding of IKKγ to the IKKα and IKKβ subunits. This leads to the phosphorylation 
of the IkB rendering the free NF-ĸB to translocate to the nucleus thus initiating 
the expression of genes involved in the production of pro-inflammatory cytokines 
and osteoclastogenesis. The nanoparticle cargo delivers the NBD inhibitory 
peptide in to the cell and the peptide prevents the binding of IKKγ to the Nemo 
binding domain, thus blocking the downstream pathway that leads to the 
production of NF-ĸB. This results in the prevention of inflammation and bone 
loss. 
 
Future studies might be directed at testing the nanoparticles using the other 
bacteria associated with the pathogenesis of the disease. Indeed, this study might 
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provide data on differential expression of cytokines by different bacteria and also 
the amount of suppression of the inflammation and bone loss by the nanoparticles. 
Also, nanoparticles with another peptide as a control can be used to check if the 
action is caused by the NBD nanoparticles. Characterization of the cell types that 
are involved in cytokine production is another direction of future studies. As the 
nanoparticle can be used as a drug delivery vehicle for other peptides, other 
processes of the NFkB pathway can be blocked.  
 
In summary, our experimental results have indicated that this novel peptide- 
nanoparticle complex is effective to inhibit pro-inflammatory cytokine production, 
and RANKL-induced osteoclastogenesis. This nanoparticle inhibits pro-
inflammatory cytokine expression in gingivae and prevents alveolar bone loss in a 
murine model for periodontitis. This novel nanoparticle showed significant 
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